Literature DB >> 3202231

Low-dose fourth ventricular bombesin selectively suppresses food intake.

E E Ladenheim1, R C Ritter.   

Abstract

Bombesin (BBS) administered into the lateral cerebral ventricles suppresses food intake. Suppression of food intake, however, is accompanied by arousal of competing behaviors such as grooming and increased locomotion, which are atypical of normal satiety. We have found that BBS infused into the fourth cerebral ventricle in rats reduces food intake at doses one-tenth to one-hundredth of those required via the lateral ventricle. In addition, the lowest fourth ventricular dose that significantly reduced food intake did not increase locomotor activity. These data suggest that the hindbrain may be a more sensitive site for BBS-induced suppression of feeding than forebrain sites and that feeding and locomotor effects of BBS may involve dissociable neural substrates.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3202231     DOI: 10.1152/ajpregu.1988.255.6.R988

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Gastrin-releasing peptide messenger ribonucleic acid expression in the hypothalamic paraventricular nucleus is altered by melanocortin receptor stimulation and food deprivation.

Authors:  Ellen E Ladenheim; Robert R Behles; Sheng Bi; Timothy H Moran
Journal:  Endocrinology       Date:  2008-09-25       Impact factor: 4.736

2.  Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight.

Authors:  H J Grill; A B Ginsberg; R J Seeley; J M Kaplan
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

3.  Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor.

Authors:  Andreas Stengel; Miriam Goebel; Lixin Wang; Jean Rivier; Peter Kobelt; Hubert Mönnikes; Nils W G Lambrecht; Yvette Taché
Journal:  Endocrinology       Date:  2009-10-01       Impact factor: 4.736

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.